0000950170-23-067881.txt : 20231204 0000950170-23-067881.hdr.sgml : 20231204 20231204194011 ACCESSION NUMBER: 0000950170-23-067881 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20231204 DATE AS OF CHANGE: 20231204 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: AMGEN INC CENTRAL INDEX KEY: 0000318154 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 953540776 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-37702 FILM NUMBER: 231464845 BUSINESS ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 BUSINESS PHONE: (805)447-1000 MAIL ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 FORMER COMPANY: FORMER CONFORMED NAME: AMGEN DATE OF NAME CHANGE: 19870305 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Grygiel Nancy A. CENTRAL INDEX KEY: 0001816414 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 144 1 primary_doc.xml 144 0001816414 XXXXXXXX LIVE 0000318154 Amgen Inc. 001-37702 One Amgen Center Drive Thousand Oaks CA 91320 805-447-1603 Nancy A. Grygiel Officer Common Stock Raymond James & Associates, Inc.

880 Carillon Parkway St. Petersburg FL 33716

2096 572275.70 535178027 12/04/2023 Nasdaq Common Stock 11/05/2022 Restricted Stock Unit Issuer N 242 11/05/2022 Equity compensation Common Stock 07/31/2022 Restricted Stock Unit Issuer N 1637 07/31/2022 Equity compensation Common Stock 04/27/2022 Restricted Stock Unit Issuer N 112 04/27/2022 Equity compensation Common Stock 04/27/2021 Restricted Stock Unit Issuer N 105 04/27/2021 Equity compensation Y Number of shares outstanding as of Form 10-Q filed on October 26, 2023. 12/04/2023 /s/ Nancy Grygiel